CoChat

Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study

Open access
Behary, Preeshila, Tharakan, George, Alexiadou, Kleopatra, Johnson, Nicholas, Wewer Albrechtsen, Nicolai J., Kenkre, Julia, Cuenco, Joyceline, Hope, David, Anyiam, Oluwaseun, Choudhury, Sirazum, Alessimii, Haya, Poddar, Ankur, Minnion, James, Doyle, Chedie, Frost, Gary, Le Roux, Carel, Purkayastha, Sanjay, Moorthy, Krishna, Dhillo, Waljit, Holst, Jens J., Ahmed, Ahmed R., Prevost, A. Toby, Bloom, Stephen R., Tan, Tricia M. · 2019 · Diabetes Care
Cited by 110

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Roux-en-Y gastric bypass (RYGB) augments postprandial secretion of glucagon-like peptide 1 (GLP-1), oxyntomodulin (OXM), and peptide YY (PYY). Subcutaneous infusion of these hormones (“GOP”), mimicking postprandial levels, reduces energy intake. Our objective was to study the effects of GOP on glycemia and body weight when given for 4 weeks to patients with diabetes and obesity. RESEARCH DESIGN AND METHODS: In this single-blinded mechanistic study, obese patients with prediabetes/diabetes were randomized to GOP (n = 15) or saline (n = 11) infusion for 4 weeks. We also studied 21 patients who had undergone RYGB and 22 patients who followed a very low-calorie diet (VLCD) as unblinded comparators. Outcomes measured were 1) body weight, 2) fructosamine levels, 3) glucose and insulin during a mixed meal test (MMT), 4) energy expenditure (EE), 5) energy intake (EI), and 6) mean glucose and measures of glucose variability during continuous glucose monitoring. RESULTS: GOP infusion was well tolerated over the 4-week period. There was a greater weight loss (P = 0.025) with GOP (mean change −4.4 [95% CI −5.3, −3.5] kg) versus saline (−2.5 [−4.1, −0.9] kg). GOP led to a greater improvement (P = 0.0026) in fructosamine (−44.1 [−62.7, −25.5] µmol/L) versus saline (−11.7 [−18.9, −4.5] µmol/L). Despite a smaller weight loss compared with RYGB and VLCD, GOP led to superior glucose tolerance after a mixed-meal stimulus and reduced glycemic variability compared with RYGB and VLCD. CONCLUSIONS: GOP infusion improves glycemia and reduces body weight. It achieves superior glucose tolerance and reduced glucose variability compared with RYGB and VLCD. GOP is a viable alternative for the treatment of diabetes with favorable effects on body weight.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc19-0449

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 14

  1. Bojsen-Møller, 2014, Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass, Diabetes, 63, 1725, 10.2337/db13-1307 · DOI · Paper page
  2. Miras, 2013, Mechanisms underlying weight loss after bariatric surgery, Nat Rev Gastroenterol Hepatol, 10, 575, 10.1038/nrgastro.2013.119 · DOI · Paper page
  3. Drucker, 2018, The ascending GLP-1 road from clinical safety to reduction of cardiovascular complications, Diabetes, 67, 1710, 10.2337/dbi18-0008 · DOI · Paper page
  4. Cohen, 2003, Oxyntomodulin suppresses appetite and reduces food intake in humans, J Clin Endocrinol Metab, 88, 4696, 10.1210/jc.2003-030421 · DOI · Paper page
  5. Neary, 2005, Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively, Endocrinology, 146, 5120, 10.1210/en.2005-0237 · DOI · Paper page
  6. Schmidt, 2014, Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men, Am J Physiol Endocrinol Metab, 306, E1248, 10.1152/ajpendo.00569.2013 · DOI · Paper page
  7. Field, 2010, PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans, Diabetes, 59, 1635, 10.2337/db09-1859 · DOI · Paper page
  8. van Strien, 1986, The Dutch Eating Behavior Questionnaire (DEBQ) for assessment of restrained, emotional, and external eating behavior, Int J Eat Disord, 5, 295, 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T · doi:10.1002/1098-108x(198602)5:2<295::aid-eat2260050209>3.0.co;2-t
  9. Hill, 2013, Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2, Diabetes Care, 36, 2324, 10.2337/dc12-0607 · DOI
  10. Blundell, 2017, Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity, Diabetes Obes Metab, 19, 1242, 10.1111/dom.12932 · DOI · Paper page
  11. Schmidt, 2016, Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial, Int J Obes, 40, 281, 10.1038/ijo.2015.162 · DOI
  12. Tharakan, 2017, Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass, Eur J Endocrinol, 177, 455, 10.1530/EJE-17-0446 · DOI · Paper page
  13. Hare, 2009, Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus, J Clin Endocrinol Metab, 94, 4679, 10.1210/jc.2009-0921 · DOI · Paper page
  14. Salinari, 2017, Downregulation of insulin sensitivity after oral glucose administration: evidence for the anti-incretin effect, Diabetes, 66, 2756, 10.2337/db17-0234 · DOI

Cited by

Metadata

Authors
Behary, P., Tharakan, G., Alexiadou, K., Johnson, N., Wewer Albrechtsen, N. J., Kenkre, J., Cuenco, J., Hope, D., Anyiam, O., Choudhury, S., Alessimii, H., Poddar, A., Minnion, J., Doyle, C., Frost, G., Le Roux, C., Purkayastha, S., Moorthy, K., Dhillo, W., Holst, J. J., Ahmed, A. R., Prevost, A. T., Bloom, S. R., & Tan, T. M.
Venue
Diabetes Care
Published
2019-06-08
Volume
42
Issue
8
Pages
1446-1453
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2948323429
Cited by
110
References
15
FWCI
11.36
Type
journal article
Language
en
Open access
green
Funders
Medical Research Council (MRC) Experimental Challenge Grant (MR/K02115X/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.